Despite the return of restrictions in early 2022 as cases of COVID-19 once again surged in China, dermatologicals is set to record another positive performance, following high value growth the previous year as local consumers started to spend greater time outside of the home, including exercise, lea...
Topical allergy remedies is set to be the fastest growing dermatologicals category in 2022, as the incidence of allergies is on the rise and consumers have become more and more confident in self-medication. Changes in eating habits and poor food quality are amongst the factors contributing to a grea...
The performance of dermatologicals was not significantly affected by the Coronavirus (COVID-19) pandemic in 2020. This was mainly due to the specific nature of the ailments and conditions dermatologicals are used to relieve. While increased levels of stress and anxiety during the pandemic saw retail...
Whilst medicated shampoo recorded value growth in 2022 due to inflation and price increases, volume sales experienced decline in the year. This drop in sales is attributable to the increase in selling prices in relation to the purchasing power of Tunisian consumers, and as the majority of products a...
Sales in hair loss treatments follow seasonal trends, along with health-related factors. Hair weakens and becomes vulnerable to shedding due to reasons such as seasonality (seasonal transitions), stress, hormonal changes, and thermal applications. Therefore, an increase in sales is seen in the sprin...
The expansion of the dermatologicals category has been mainly driven by the strong growth of medicated shampoos, hair loss treatments and paediatric dermatologicals. The stress related to COVID-19 and, more recently, to high energy and commodity prices has caused multiple scalp problems amongst cons...
Having fallen sharply in 2020, retail constant value sales (2021 prices) of dermatologicals began to recover in 2021, and this trend extended into 2022—albeit with a more modest growth rate. However, retail constant value sales remained well below their pre-pandemic peak. Euromonitor In...
Demand for antiparasitics/lice (head and body) treatments in Ireland fell sharply over 2020-2021 as schools were closed for lengthy periods and social distancing was widely observed as part of the national effort to curb the spread of COVID-19. With schools having since fully reopened and levels of ...
Dermatologicals is projected to see positive retail volume and current value growth over 2022. All significant categories are set to see high single-digit or double-digit retail current value increments. Antiparasitics/lice (head and body) treatments is expected to see the highest retail volume and ...
Dermatologicals is set to see significantly stronger growth in 2022 compared to 2020 and 2021, in current value terms. During 2020-2021 consumers spent considerably more time at home and thus many dermatological complaints took a back seat, with social distancing and the lack of activity away from t...